Ocugen
OCGN · NASDAQ
Bulios Fair Price
$0.65
38.7% downside
Trenutna cena
$1.06
Po podatkih Bulios Fair Price je delnica OCGN trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
O podjetju
Ocugen (OCGN) is a biopharmaceutical company focused on the development and commercialization of innovative therapeutic products. Its primary goal is to provide patients with high therapeutic value medicines and contribute to improving their health outcomes. The company specializes in the treatment of ocular diseases, including rare eye disorders. Ocugen stock is suitable for investors interested in the biotechnology sector and those who want to support innovative treatment approaches. Add Ocugen stock to your watchlist on Bulios and gain access to the latest information about this company that is pushing the boundaries of ocular disease management.
V vašem jeziku še ni na voljo, zato je besedilo v angleščini.
Sector
Healthcare
Industry
Biotechnology
CEO
Shankar Musunuri
Employees
116
Headquarters
Malvern
Prihajajoči dogodki
Earnings
Upcoming earnings report